Are there cost benefits to fentanyl for breakthrough pain?

Journal of Pain and Symptom Management

Volumn 44, Issue 3, 2012, Pages e1-

  Davis, Mellar P ^a,b  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; MORPHINE;

BREAKTHROUGH PAIN; COST BENEFIT ANALYSIS; DRUG COST; DRUG SAFETY; HUMAN; LETTER;

EID: 84865693335     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2012.06.002     Document Type: Letter

References (2)

1. M. Fallon, C. Reale, and A. Davies Efficacy and safety of fentanyl pectin nasal spray compared with immediate-release morphine sulfate tablets in the treatment of breakthrough cancer pain: a multicenter, randomized, controlled, double-blind, double-dummy multiple-crossover study J Support Oncol 9 2011 224 231
2. M.A. Ashburn, K.A. Slevin, and J. Messina The efficacy and safety of fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic pain Anesth Analg 112 2011 693 702